Blog

Alzheimer’s disease impacts 6 million Americans, but focused ultrasound could offer hope. This blog by the Foundation’s Director of Clinical Relationships explores how focused ultrasound is now being investigated as a revolutionary therapy that could offer hope to patients.

The annual J.P. Morgan Healthcare Conference took place January 8–11, 2024, in San Francisco. This blog by senior advisor Patrick Edelmann highlights notable topics from the conference, such as artificial intelligence and neuromodulation.

Securing reimbursement for new therapies like focused ultrasound is critical to its widespread adoption. This blog by Michael Broad, PhD, the Foundation’s Data Strategy Director, discusses key milestones from the past year.

The Foundation’s chief technology officer, Rick Hamilton, shares how the Foundation team reviewed more than 130 papers to assess how artificial intelligent (AI) may improve clinical solutions in focused ultrasound. Learn about the three areas that emerged as fields of interest and what the Foundation is doing to assist as the focused ultrasound community embraces this burgeoning technology. This blog is also available as a vlog.